One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1182/blood.v124.21.293.293
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Dec 6, 2014 |
 Citations: 18 |
Affiliation: Dana-Farber Cancer Institute, University of Nebraska Medical Center, Colorado Blood Cancer Institute, Columbia University Irving Medical Center, Case Western Reserve University, Mayo Clinic, Jewish Hospital, Mercy Health, Oncology Institute of Hope and Innovation, Texas Oncology, Pacific Eye Associates, Hematology Oncology Associates, St. Francis Hospital, Seagen (United States)
Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma who are Relapsed or Refractory after Frontline Therapy
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
